Research And Markets Research And Markets
0 CHECKOUT

Search for: "Global Hemophilia Treatment Market 2010-2014"

Global Hemophilia B Market 2015-2019 - Industry Analysis

About hemophilia B Hemophilia B, also called the Christmas disease, is a blood coagulation disorder due to the deficiency or improper function of factor IX. It is inherited in an X-linked recessive...

Published:  September 2015
Price:  From EURUSDGBP

Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline

“Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline”, provides in-depth analysis of unmet needs, drivers...

Published:  September 2011
Price:  From EURUSDGBP

Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth

“Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth” provides in-depth analysis of drivers and barriers that...

Published:  September 2011
Price:  From EURUSDGBP

Investigation Report on China's Recombinant Factor VIII Market, 2010-2019

Hemophilia is a hereditary bleeding disorder caused by a lack of clotting factor VIII or IX, though not rare, which affects mostly males. Hemophilia A (clotting factor VIII deficiency) is the most common...

Published:  June 2015
Price:  From EURUSDGBP

Investigation Report on China's Recombinant Factor VIII Market, 2010-2019 (Chinese Version)

Hemophilia is a hereditary bleeding disorder caused by a lack of clotting factor VIII or IX, though not rare, which affects mostly males. Hemophilia A (clotting factor VIII deficiency) is the most common...

Published:  June 2015
Price:  From EURUSDGBP

The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities

“The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities” provides in-depth analysis of unmet needs,...

Published:  March 2010
Price:  From EURUSDGBP

Global Blood Plasma Market Report: 2016 Edition

The raw material for blood plasma industry is the liquid that is a component of blood called blood plasma. Blood plasma makes up approximately 55% of the total blood volume. Blood plasma is pale yellow...

Published:  June 2016
Price:  From EURUSDGBP

Human Albumin and Factor Vlll (FVIII) Markets: An Analysis

The global blood plasma-derived products market has shown consistent growth over the period 2002-2009 and the rapid increase in cases of Hemophilia, low treatment cost to patients and rising ageing...

Published:  April 2011
Price:  From EURUSDGBP

Global Gene Therapy Market Forecast to 2020

Gene therapy is one of the most widely researched fields in the healthcare industry. The high potential of gene therapy to cure various chronic diseases makes it a popular research area. Various researches...

Published:  January 2016
Price:  From EURUSDGBP

Global Blood coagulation analyzer market 2016-2020

About the Blood Coagulation Analyzer Market A blood coagulation analyzer is a testing device used in clinical laboratories to test the coagulation efficacy of blood and assess bleeding disorders...

Published:  June 2016
Price:  From EURUSDGBP

World Biosimilars/Follow-on-Biologics Market - Opportunities and Forecasts, 2014 - 2020

Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference...

Published:  September 2015
Price:  From EURUSDGBP

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home Care Setting) - Global Forecast to 2020

The injectable drug delivery market is expected to reach $547.8 billion by 2020 from $326.1 billion in 2015, growing at a CAGR of 12.0% from 2015 to 2020. The market is categorized on the basis of type,...

Published:  August 2015
Price:  From EURUSDGBP

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

The service oriented and dynamic nature of the healthcare industry has led to the discovery of a plethora of treatment options for a wide range of ailments.However, there are certain diseases, termed...

Published:  March 2015
Price:  From EURUSDGBP

Global Human Growth Hormone Market Report: 2012 Edition

Pituitary- the master gland of human body is responsible for controlling crucial hormonal secretion which in turn regulates other key aspects of human body such as temperature, growth, thyroid functioning,...

Published:  October 2012
Price:  From EURUSDGBP

Biosimilars (2009 - 2014)

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities...

Published:  September 2009
Price:  From EURUSDGBP

Blood Banking and Blood Products - Global Strategic Business Report

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Group/Types: Blood Components and Plasma Products (Whole Blood & Cellular Components;...

Published:  October 2015
Price:  From EURUSDGBP

Biogen Idec Inc. (BIIB) - Financial and Strategic SWOT Analysis Review

Biogen Idec Inc. (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The...

Published:  March 2015
Price:  From EURUSDGBP
Loading Indicator